Previous 10 | Next 10 |
2023-05-15 12:03:23 ET Twist Bioscience Corporation ( NASDAQ: TWST ) added ~16% on Monday to mark the biggest intraday gain since November after its senior vice president Dennis Cho disclosed the purchase of 10K shares of the synthetic biology company. According to a regul...
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present at Imec Technology Forum (ITF) ...
2023-05-05 12:31:05 ET Twist Bioscience Corporation (TWST) Q2 2023 Earnings Conference Call May 05, 2023, 08:00 AM ET Company Participants Angela Bitting - SVP, Corporate Affairs and ESG Officer Emily Leproust - CEO and Co-Founder James Thorburn - CFO Confe...
2023-05-04 12:36:33 ET Twist Bioscience ( NASDAQ: TWST ) is scheduled to announce FQ2 earnings results on Friday, May 5th, before market open. The consensus EPS Estimate is -$1.10 (+2.7% Y/Y) and the consensus Revenue Estimate is $56.59M (+17.6% Y/Y). Over the last 2 y...
2023-04-27 11:52:07 ET Twist Bioscience ( NASDAQ: TWST ) and Aster Insights are launching a next generation oncology panel AsterExome for cancer research. The company said the panel can simultaneously enable whole exome sequencing (WES) with additional coverage for target regi...
Comprehensive capture panel to enable enhanced bioinformatics-based oncology research Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Aster Insights , a bioinf...
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a collaboration with Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura., “Astellas”...
TCR and CAR libraries enable comprehensive screening of combinations of custom gene parts including domains from TCRs and CARs Information about the offering available at AACR Annual Meeting 2023 Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to su...
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2023 second quarter ended March 31, 2023, before the opening ...
Storage Veteran Appointments Bring Diverse Technical Expertise to Help Lead Implementation of Industry Standards for DNA Data Storage The DNA Data Storage Alliance, a SNIA Technology Affiliate, formed in 2020 by Illumina, Inc. (NASDAQ: ILMN), Microsoft (Nasdaq: MSFT), Twist Bios...
News, Short Squeeze, Breakout and More Instantly...
Twist Bioscience Corporation Company Name:
TWST Stock Symbol:
NASDAQ Market:
Twist Bioscience Corporation Website:
Pure Biologics’ exploratory Phase 0 study to evaluate pharmacodynamic activity of PBA-0405 in solid tumors Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today a...
Company to host conference call at 8:00 AM ET Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2024 th...
Express Genes enable faster turnaround times Twist Express Antibodies, CHO starting at 13 business days Twist Express Antibodies, HEK293 starting at 10 business days Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of ...